Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa

BACKGROUND: HIV endpoint-driven clinical trials increasingly provide oral pre-exposure prophylaxis (PrEP) as standard of prevention during the trial, however, among participants desiring to continue using PrEP at trial exit, little is known about post-trial PrEP access and continued use. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Beesham, Ivana, Milford, Cecilia, Smit, Jenni, Joseph Davey, Dvora L., Baeten, Jared M., Heffron, Renee, Beksinska, Mags, Mansoor, Leila E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286415/
https://www.ncbi.nlm.nih.gov/pubmed/37349816
http://dx.doi.org/10.1186/s12889-023-16139-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286415/
https://www.ncbi.nlm.nih.gov/pubmed/37349816
http://dx.doi.org/10.1186/s12889-023-16139-z

Ejemplares similares